Safe and sound

Gene Therapy

Volumn 12, Issue 21, 2005, Pages 1542-1543

  Mountz, John D ^a   Chen, J ^a   Hsu, H C ^a  

^a The University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; PROSTAGLANDIN E2; RETROVIRUS VECTOR; THYMIDINE KINASE;

CELL BASED GENE THERAPY; CELLULAR DISTRIBUTION; CLINICAL TRIAL; EX VIVO STUDY; FIBROBLAST; GENE TARGETING; HUMAN; IN VITRO STUDY; NONHUMAN; NOTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIDE EFFECT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ANIMAL; ARTICLE; GENE THERAPY; GENETIC TRANSDUCTION; METHODOLOGY;

ANIMALS; ARTHRITIS, RHEUMATOID; GENE THERAPY; HUMANS; TRANSDUCTION, GENETIC;

EID: 27544476635     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302606     Document Type: Note

References (9)

1. Evans CH et al. Gene transfer to human joints: Progress toward a gene therapy of arthritis. Proc Natl Acad Sci USA 2005; 102: 8698-8703.
2. Bresnihan B. The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis. Semin Arthritis Rheum 2001; 30: 17-20.
3. Nuki G, Bresnihan B, Bear MB, McCabe D. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: Extension phase of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002; 46: 2838-2846.
4. Kim SH et al. Ex vivo gene delivery of IL-1Ra and soluble TNF receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis. Mol Ther 2002; 6: 591-600.
5. Smeets RL et al. Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritis. Arthritis Rheum 2003; 48: 2949-2958.
6. Makarov SS et al. Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc Natl Acad Sci USA 1996; 93: 402-406.
7. Sant SM et al. Molecular lysis of synovial lining cells by in vivo herpes simplex virus-thymidine kinase gene transfer Hum Gene Ther 1998; 9: 2735-2743.
8. Hacein-Bey-Abina S et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415-419.
9. Vilaboa N et al. Novel gene switches for targeted and timed expression of proteins of interest. Mol Ther 2005; 12: 290-298.